178 related articles for article (PubMed ID: 33087512)
1. The Landscape of Glycogen Synthase Kinase-3 Beta Genomic Alterations in Cancer.
Borden BA; Baca Y; Xiu J; Tavora F; Winer I; Weinberg BA; Vanderwalde AM; Darabi S; Korn WM; Mazar AP; Giles FJ; Crawford L; Safran H; El-Deiry WS; Carneiro BA
Mol Cancer Ther; 2021 Jan; 20(1):183-190. PubMed ID: 33087512
[TBL] [Abstract][Full Text] [Related]
2. The role of glycogen synthase kinase-3β (GSK-3β) in endometrial carcinoma: A carcinogenesis, progression, prognosis, and target therapy marker.
Chen S; Sun KX; Liu BL; Zong ZH; Zhao Y
Oncotarget; 2016 May; 7(19):27538-51. PubMed ID: 27050373
[TBL] [Abstract][Full Text] [Related]
3. The mood stabilizing properties of AF3581, a novel potent GSK-3β inhibitor.
Capurro V; Lanfranco M; Summa M; Porceddu PF; Ciampoli M; Margaroli N; Durando L; Garrone B; Ombrato R; Tongiani S; Reggiani A
Biomed Pharmacother; 2020 Aug; 128():110249. PubMed ID: 32470749
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of glycogen synthase kinase 3 (GSK-3) expression and tumor budding grade in colorectal cancer: Implications for targeted therapy.
Guil-Luna S; Rivas-Crespo A; Navarrete-Sirvent C; Mantrana A; Pera A; Mena-Osuna R; Toledano-Fonseca M; García-Ortíz MV; Villar C; Sánchez-Montero MT; Krueger J; Medina-Fernández FJ; De La Haba-Rodríguez J; Gómez-España A; Aranda E; Rudd CE; Rodríguez-Ariza A
Biomed Pharmacother; 2023 Nov; 167():115592. PubMed ID: 37778272
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 beta inhibitors as novel cancer treatments and modulators of antitumor immune responses.
Sahin I; Eturi A; De Souza A; Pamarthy S; Tavora F; Giles FJ; Carneiro BA
Cancer Biol Ther; 2019; 20(8):1047-1056. PubMed ID: 30975030
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and transcriptional and functional analysis of glycogen synthase kinase-3β in Haemaphysalis longicornis (Acari, Ixodidae).
Rahman MK; You M
Parasite; 2019; 26():39. PubMed ID: 31294687
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase 3β in tumorigenesis and oncotherapy (Review).
He R; Du S; Lei T; Xie X; Wang Y
Oncol Rep; 2020 Dec; 44(6):2373-2385. PubMed ID: 33125126
[TBL] [Abstract][Full Text] [Related]
8. Positive correlation between overexpression of phospho-BAD with phosphorylated Akt at serine 473 but not threonine 308 in colorectal carcinoma.
Khor TO; Gul YA; Ithnin H; Seow HF
Cancer Lett; 2004 Jul; 210(2):139-50. PubMed ID: 15183529
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of glycogen synthase kinase-3β targeting against osteosarcoma via activation of β-catenin.
Shimozaki S; Yamamoto N; Domoto T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Miwa S; Igarashi K; Kato T; Aoki Y; Higuchi T; Hirose M; Hoffman RM; Minamoto T; Tsuchiya H
Oncotarget; 2016 Nov; 7(47):77038-77051. PubMed ID: 27780915
[TBL] [Abstract][Full Text] [Related]
10. Molecular Pathways: Revisiting Glycogen Synthase Kinase-3β as a Target for the Treatment of Cancer.
Walz A; Ugolkov A; Chandra S; Kozikowski A; Carneiro BA; O'Halloran TV; Giles FJ; Billadeau DD; Mazar AP
Clin Cancer Res; 2017 Apr; 23(8):1891-1897. PubMed ID: 28053024
[TBL] [Abstract][Full Text] [Related]
11. Glycogen synthase kinase 3 β activity is essential for Polo-like kinase 2- and Leucine-rich repeat kinase 2-mediated regulation of α-synuclein.
Kofoed RH; Betzer C; Ferreira N; Jensen PH
Neurobiol Dis; 2020 Mar; 136():104720. PubMed ID: 31881263
[TBL] [Abstract][Full Text] [Related]
12. Glycogen Synthase Kinase-3 Beta Expression Correlates With Worse Overall Survival in Non-Small Cell Lung Cancer-A Clinicopathological Series.
Alves M; Borges DP; Kimberly A; Martins Neto F; Oliveira AC; de Sousa JC; Nogueira CD; Carneiro BA; Tavora F
Front Oncol; 2021; 11():621050. PubMed ID: 33767989
[TBL] [Abstract][Full Text] [Related]
13. Glycogen Synthase Kinase 3β: A True Foe in Pancreatic Cancer.
Elmadbouh OHM; Pandol SJ; Edderkaoui M
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430630
[TBL] [Abstract][Full Text] [Related]
14. GSK-3β in DNA repair, apoptosis, and resistance of chemotherapy, radiotherapy of cancer.
Lin J; Song T; Li C; Mao W
Biochim Biophys Acta Mol Cell Res; 2020 May; 1867(5):118659. PubMed ID: 31978503
[TBL] [Abstract][Full Text] [Related]
15. Glycogen synthase kinase-3beta activity is required for androgen-stimulated gene expression in prostate cancer.
Liao X; Thrasher JB; Holzbeierlein J; Stanley S; Li B
Endocrinology; 2004 Jun; 145(6):2941-9. PubMed ID: 14988390
[TBL] [Abstract][Full Text] [Related]
16. MiR-155 affects renal carcinoma cell proliferation, invasion and apoptosis through regulating GSK-3β/β-catenin signaling pathway.
Wei RJ; Zhang CH; Yang WZ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5034-5041. PubMed ID: 29228417
[TBL] [Abstract][Full Text] [Related]
17. Multifaceted Roles of GSK-3 in Cancer and Autophagy-Related Diseases.
Mancinelli R; Carpino G; Petrungaro S; Mammola CL; Tomaipitinca L; Filippini A; Facchiano A; Ziparo E; Giampietri C
Oxid Med Cell Longev; 2017; 2017():4629495. PubMed ID: 29379583
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of glycogen synthase kinase-3β (GSK-3β) enhances skeletal muscle oxidative metabolism.
Theeuwes WF; Gosker HR; Langen RCJ; Verhees KJP; Pansters NAM; Schols AMWJ; Remels AHV
Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3075-3086. PubMed ID: 28943449
[TBL] [Abstract][Full Text] [Related]
19. Hypoxic inactivation of glycogen synthase kinase-3β promotes gastric tumor growth and angiogenesis by facilitating hypoxia-inducible factor-1 signaling.
Ko YS; Cho SJ; Park J; Choi Y; Lee JS; Youn HD; Kim WH; Kim MA; Park JW; Lee BL
APMIS; 2016 Sep; 124(9):748-56. PubMed ID: 27365055
[TBL] [Abstract][Full Text] [Related]
20. Pan-cancer analysis of copy number changes in programmed death-ligand 1 (PD-L1, CD274) - associations with gene expression, mutational load, and survival.
Budczies J; Bockmayr M; Denkert C; Klauschen F; Gröschel S; Darb-Esfahani S; Pfarr N; Leichsenring J; Onozato ML; Lennerz JK; Dietel M; Fröhling S; Schirmacher P; Iafrate AJ; Weichert W; Stenzinger A
Genes Chromosomes Cancer; 2016 Aug; 55(8):626-39. PubMed ID: 27106868
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
